By Dhirendra Tripathi
Investing.com – AstraZeneca ADRs (NASDAQ: AZN ) traded 1% higher in Tuesday’s premarket as the proposed changes to rules governing travel to the U.S. will accommodate those vaccinated by the company’s Covid-19 shots.
The Oxford-AstraZeneca vaccine is still not approved by the U.S. drugs regulator. But according to comments made by Anthony Fauci, a top infectious diseases expert who heads the U.S. response to the pandemic, it looks like those vaccinated by the vaccine will face no problem entering the U.S.
“Given we have a substantial amount of information on the AZ vaccine . . . I would predict it would not be a problem,” he said, according to The Times of London.
The U.S. eased travel rules Monday, allowing fully vaccinated travelers to enter the country from November onward without them having to quarantine. They will have to present a proof of vaccination before boarding and proof of a negative Covid-19 test taken within three days of the flight.
The easing of travel rules and Fauci’s comments added to the positive sentiment for the stock generated by the findings of a study involving the company’s potential drug to treat breast cancer. The company on Saturday said Enhertu, an antibody drug conjugate, demonstrated superior outcomes compared to the existing treatment. The company is jointly developing the drug with Japan’s Daiichi Sankyo (T: 4568 ).
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.